Crofelemer is a plant-based drug used in adults for the treatment of non-infectious diarrhea associated with antiretroviral treatment for Human Immunodeficiency Virus (HIV) infection. It has been studied as prophylaxis for diarrhea in patients with HER-2 positive breast cancer receiving treatment with trastuzumab, pertuzumab, and taxane regimens.

View Crofelemer Evaluation Table